Get the Stockscreener App
32.04
0.74%
-0.24
After Hours:
32.04
Springworks Therapeutics Inc stock is traded at $32.04, with a volume of 642.84K.
It is down -0.74% in the last 24 hours and down -23.18% over the past month.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.
See More
Previous Close:
$32.28
Open:
$32.18
24h Volume:
642.84K
Relative Volume:
0.74
Market Cap:
$2.40B
Revenue:
-
Net Income/Loss:
$-301.06M
P/E Ratio:
-6.5791
EPS:
-4.87
Net Cash Flow:
$-248.01M
1W Performance:
-2.55%
1M Performance:
-23.18%
6M Performance:
-34.90%
1Y Performance:
+38.58%
1-Day Range:
$31.66
$32.85
1-Week Range:
$31.46
$33.29
52-Week Range:
$18.00
$53.92
Springworks Therapeutics Inc Stock (SWTX) Company Profile
Name
Springworks Therapeutics Inc
Sector
Industry
Phone
203-883-9490
Address
100 WASHINGTON BOULEVARD, STAMFORD, CT
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-05-24 | Initiated | Guggenheim | Buy |
| Dec-01-22 | Initiated | BofA Securities | Buy |
| Jan-19-21 | Reiterated | H.C. Wainwright | Buy |
| Oct-29-20 | Reiterated | H.C. Wainwright | Buy |
| May-05-20 | Initiated | Barclays | Overweight |
| Mar-19-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Mar-04-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-21-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-04-19 | Initiated | H.C. Wainwright | Buy |
| Oct-08-19 | Initiated | Cowen | Outperform |
| Oct-08-19 | Initiated | Goldman | Buy |
| Oct-08-19 | Initiated | JP Morgan | Overweight |
| Oct-08-19 | Initiated | Wedbush | Outperform |
View All
Springworks Therapeutics Inc Stock (SWTX) Latest News
SpringWorks Therapeutics Inc (SWTX) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Driehaus Capital Management LLC Sells 26,993 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
D. E. Shaw & Co. Inc. Boosts Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Selling Buzz: SpringWorks Therapeutics Inc [SWTX] Chief Executive Officer Islam Saqib sells 49,000 shares of the company – Knox Daily - Knox Daily
SpringWorks Therapeutics (NASDAQ:SWTX) shareholders are still up 68% over 5 years despite pulling back 8.7% in the past week - Simply Wall St
Maverick Capital Ltd. Has $97.96 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
There is no way SpringWorks Therapeutics Inc (SWTX) can keep these numbers up - SETE News
Duquesne Family Office LLC Makes New $38.48 Million Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Magnetar Financial LLC Makes New Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Affinity Asset Advisors LLC Has $2.64 Million Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
SpringWorks Therapeutics Inc (SWTX) stock on the rise: An overview - US Post News
Marshall Wace LLP Sells 633,505 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Marshall Wace LLP Sells 633,505 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
State of New Jersey Common Pension Fund D Reduces Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Recent Insider Activity Could Benefit SpringWorks Therapeutics Inc (SWTX) - Knox Daily
When Would Be The Best Time To Buy SpringWorks Therapeutics Inc (NASDAQ: SWTX) Stock? - Stocks Register
Profund Advisors LLC Raises Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Financial Health Check: Examining SpringWorks Therapeutics Inc (SWTX)’s Key Ratios - The Dwinnex
XTX Topco Ltd Invests $621,000 in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
XTX Topco Ltd Makes New $621,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Proactive Strategies - Stock Traders Daily
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Acquired by Mutual of America Capital Management LLC - Defense World
Mutual of America Capital Management LLC Increases Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Massachusetts Financial Services Co. MA Purchases 69,227 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Massachusetts Financial Services Co. MA Buys 69,227 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Stock Holdings Lifted by Oppenheimer Asset Management Inc. - Defense World
Chief Executive Officer Islam Saqib sold 49,000 shares of SpringWorks Therapeutics Inc [SWTX] - Knox Daily
Brokerages Set SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Target Price at $68.50 - Defense World
Seven Eight Capital LP Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
E Fund Management Co. Ltd. Increases Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Seven Eight Capital LP Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics Inc (SWTX) requires closer examination - US Post News
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Stake Lessened by Quest Partners LLC - Defense World
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Acquired by Arizona State Retirement System - Defense World
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Acquired by Rhumbline Advisers - Defense World
SpringWorks Therapeutics Inc (SWTX) rating initates by Guggenheim - Knox Daily
SWTX's NDA for Rare Tumor Drug Gets Priority Review From FDA - MSN
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Top investors say SpringWorks Therapeutics Inc (SWTX) ticks everything they need - SETE News
Los Angeles Capital Management LLC Sells 554 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
SpringWorks Therapeutics Inc (SWTX) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Ratio Review: Analyzing SpringWorks Therapeutics Inc (SWTX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Victory Capital Management Inc. Grows Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics Inc [NASDAQ: SWTX] Sees Decrease in Stock Value - Knox Daily
Victory Capital Management Inc. Raises Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
SpringWorks Therapeutics (NASDAQ:SWTX) Trading Down 4% - MarketBeat
(SWTX) Technical Pivots with Risk Controls - Stock Traders Daily
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by TD Asset Management Inc - MarketBeat
TD Asset Management Inc Lowers Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Understanding the Risks of Investing in SpringWorks Therapeutics Inc (SWTX) - Knox Daily
Have you been able to find a good deal on SpringWorks Therapeutics Inc’s shares? - US Post News
Springworks Therapeutics Inc Stock (SWTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Springworks Therapeutics Inc Stock (SWTX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Edris Badreddin | Chief Operating Officer |
Sep 03 '24 |
Sale |
40.65 |
20,000 |
812,954 |
229,600 |
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):